What causes very low total cholesterol?

Very low total cholesterol (under 120 mg/dL) can result from malnutrition, hyperthyroidism, liver disease, certain cancers, genetic conditions, or malabsorption disorders. While less common than high cholesterol, it requires medical evaluation to identify and treat the underlying cause.

Questions on this topic?Ask Sai, our AI longevity expert.
Ask Sai

Understanding Low Total Cholesterol

While much attention is given to high cholesterol and its cardiovascular risks, very low total cholesterol can also signal underlying health issues. Total cholesterol below 120 mg/dL is considered unusually low, and levels under 100 mg/dL warrant immediate medical evaluation. Unlike high cholesterol, which often develops from lifestyle factors, very low cholesterol typically indicates an underlying medical condition affecting how your body produces or processes this essential substance.

Cholesterol plays vital roles in your body beyond what many people realize. It forms the structural foundation of cell membranes, serves as a precursor for hormone production (including sex hormones and cortisol), aids in vitamin D synthesis, and helps produce bile acids necessary for fat digestion. When cholesterol levels drop too low, these essential functions can become compromised.

Primary Causes of Very Low Cholesterol

Malnutrition and Dietary Insufficiency

Severe malnutrition remains one of the most common causes of very low cholesterol. This can occur due to eating disorders like anorexia nervosa, extreme restrictive diets, or inadequate food access. When your body lacks sufficient dietary fats and calories, cholesterol production decreases significantly. Additionally, protein-energy malnutrition affects the liver's ability to synthesize cholesterol and the lipoproteins that transport it through your bloodstream.

Total Cholesterol Levels and Clinical Significance

Total Cholesterol (mg/dL)CategoryHealth ImplicationsRecommended Action
Below 100<100 mg/dLDangerously LowHigh risk of hemorrhagic stroke, severe malnutrition, critical illnessImmediate medical evaluation required
100-119100-119 mg/dLVery LowPossible underlying disease, nutritional deficiency, malabsorptionMedical evaluation recommended
120-139120-139 mg/dLLowMay indicate mild malnutrition or metabolic issuesMonitor and investigate if symptomatic
140-200140-200 mg/dLOptimalIdeal range for most adultsMaintain healthy lifestyle
201-239201-239 mg/dLBorderline HighIncreased cardiovascular riskLifestyle modifications recommended
240 and above≥240 mg/dLHighSignificant cardiovascular riskMedical intervention often needed

Total cholesterol should be interpreted alongside other lipid markers and clinical context for accurate assessment.

Even without overt malnutrition, extremely low-fat diets can contribute to declining cholesterol levels. While reducing saturated fat intake benefits cardiovascular health, completely eliminating dietary fats can lead to deficiencies in fat-soluble vitamins (A, D, E, and K) and inadequate cholesterol production.

Hyperthyroidism and Thyroid Disorders

An overactive thyroid gland significantly impacts cholesterol metabolism. Hyperthyroidism accelerates your metabolic rate, causing rapid cholesterol clearance from the bloodstream. The excess thyroid hormones increase the activity of LDL receptors on liver cells, pulling more cholesterol from circulation. They also enhance the conversion of cholesterol to bile acids, further depleting cholesterol stores.

Graves' disease, the most common cause of hyperthyroidism, frequently presents with low total cholesterol as an early sign. Other symptoms include unexplained weight loss, rapid heartbeat, tremors, and heat intolerance. Regular thyroid function testing can help identify this condition before it causes serious complications.

Liver Disease and Dysfunction

Your liver produces approximately 80% of your body's cholesterol, making liver health crucial for maintaining normal cholesterol levels. Chronic liver diseases like cirrhosis, hepatitis, and fatty liver disease can severely impair cholesterol synthesis. As liver function declines, so does its ability to produce cholesterol and the apolipoprotein components of lipoproteins.

Advanced liver disease often presents with multiple metabolic abnormalities beyond low cholesterol, including decreased albumin production, impaired blood clotting, and accumulation of toxins normally cleared by the liver. The severity of cholesterol reduction often correlates with the degree of liver dysfunction, making cholesterol levels a useful marker for monitoring liver disease progression.

Medical Conditions Associated with Low Cholesterol

Cancer and Malignancy

Several types of cancer can cause very low cholesterol levels, particularly hematologic malignancies like leukemia and lymphoma. Cancer cells have high metabolic demands and may consume large amounts of cholesterol for rapid cell division. Additionally, cancer-related inflammation and cytokine release can suppress cholesterol synthesis in the liver.

Research has shown that unexplained drops in cholesterol levels may precede cancer diagnosis by several years. While low cholesterol doesn't cause cancer, it can serve as an early warning sign, particularly when accompanied by other symptoms like unexplained weight loss, fatigue, or changes in blood counts.

Malabsorption Disorders

Conditions affecting nutrient absorption in the intestines can lead to very low cholesterol levels. Celiac disease, Crohn's disease, and chronic pancreatitis interfere with fat absorption, reducing both dietary cholesterol intake and the raw materials needed for cholesterol synthesis. These conditions often cause deficiencies in fat-soluble vitamins alongside low cholesterol.

Small intestinal bacterial overgrowth (SIBO) and parasitic infections can also impair fat absorption. Patients with these conditions typically experience chronic diarrhea, bloating, and weight loss in addition to low cholesterol levels. Proper diagnosis and treatment of the underlying malabsorption disorder usually helps normalize cholesterol levels.

Genetic and Inherited Conditions

Rare genetic disorders can cause extremely low cholesterol levels from birth. Abetalipoproteinemia and hypobetalipoproteinemia result from mutations affecting apolipoprotein B production, preventing normal formation of cholesterol-carrying lipoproteins. These conditions often present in childhood with fat malabsorption, neurological problems, and vitamin deficiencies.

Familial hypobetalipoproteinemia, a less severe genetic condition, may cause moderately low cholesterol levels without significant symptoms. However, affected individuals may have increased risk of fatty liver disease and require monitoring for fat-soluble vitamin deficiencies. Genetic testing can confirm these diagnoses when suspected based on family history and clinical presentation.

Symptoms and Health Implications

Very low cholesterol can manifest through various symptoms, though many people remain asymptomatic until complications develop. Common symptoms include fatigue and weakness, mood changes including depression and anxiety, hormonal imbalances affecting menstrual cycles or libido, poor wound healing, and increased susceptibility to infections. These symptoms result from cholesterol's essential roles in hormone production, cell membrane integrity, and immune function.

The health implications of chronically low cholesterol extend beyond immediate symptoms. Research has linked very low cholesterol levels to increased risk of hemorrhagic stroke, as cholesterol helps maintain blood vessel integrity. Mental health effects are particularly concerning, with studies showing associations between low cholesterol and increased risk of depression, anxiety, and even suicidal behavior. The exact mechanisms remain under investigation but likely involve disrupted neurotransmitter synthesis and cell membrane function in the brain.

Diagnostic Approach and Testing

Diagnosing the cause of very low cholesterol requires comprehensive evaluation beyond a simple lipid panel. Initial testing should include a complete metabolic panel to assess liver and kidney function, thyroid function tests (TSH, Free T4, Free T3), complete blood count to screen for hematologic abnormalities, and inflammatory markers like C-reactive protein. Additional specialized tests may include vitamin levels (especially fat-soluble vitamins), cortisol and other hormone levels, and specific markers for malabsorption disorders.

Regular monitoring of cholesterol levels helps track treatment response and ensure levels don't drop dangerously low. For individuals with known risk factors or symptoms suggesting low cholesterol, periodic comprehensive testing can identify problems early. Home testing options now make it convenient to monitor cholesterol and related biomarkers without frequent clinic visits.

Treatment Strategies and Management

Addressing Underlying Causes

Successful treatment of very low cholesterol depends on identifying and addressing the underlying cause. For hyperthyroidism, antithyroid medications, radioactive iodine, or surgery can normalize thyroid function and subsequently improve cholesterol levels. Liver disease management focuses on treating the specific condition while supporting overall liver function through appropriate nutrition and avoiding hepatotoxic substances.

Malabsorption disorders require targeted therapy based on the specific diagnosis. Celiac disease responds to strict gluten avoidance, while inflammatory bowel diseases may need immunosuppressive medications. Pancreatic enzyme replacement helps patients with chronic pancreatitis absorb fats more effectively. Cancer treatment, when successful, often leads to cholesterol normalization as the malignancy resolves.

Nutritional Interventions

Dietary modifications play a crucial role in managing low cholesterol, particularly when malnutrition contributes to the problem. Increasing healthy fat intake from sources like olive oil, avocados, nuts, and fatty fish provides raw materials for cholesterol synthesis. Adequate protein intake supports liver function and lipoprotein production. For those with malabsorption, medium-chain triglycerides (MCTs) may be better tolerated than long-chain fats.

Supplementation often becomes necessary, especially for fat-soluble vitamins that require adequate cholesterol for absorption and transport. Vitamin D, vitamin E, vitamin K, and vitamin A supplements may be prescribed based on individual deficiency patterns. Working with a registered dietitian can help develop a personalized nutrition plan that addresses both the low cholesterol and any underlying nutritional deficiencies.

When to Seek Medical Attention

Immediate medical evaluation is warranted for total cholesterol levels below 100 mg/dL or when low cholesterol accompanies concerning symptoms. Red flags include unexplained weight loss exceeding 10% of body weight, persistent fatigue unresponsive to rest, changes in mental status or mood, signs of malabsorption like chronic diarrhea or fatty stools, and symptoms suggesting thyroid dysfunction or liver disease.

Regular monitoring becomes essential for anyone with identified causes of low cholesterol. This includes periodic comprehensive metabolic panels, nutritional assessments, and monitoring for complications. Early intervention can prevent serious consequences and improve overall health outcomes. Don't dismiss very low cholesterol as simply the opposite of a cardiovascular risk factor—it requires thorough evaluation and appropriate management based on the underlying cause.

References

  1. Ravnskov, U., Diamond, D. M., Hama, R., Hamazaki, T., Hammarskjöld, B., Hynes, N., ... & Sundberg, R. (2016). Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: a systematic review. BMJ open, 6(6), e010401.[Link][DOI]
  2. Elmehdawi, R. (2008). Hypolipidemia: a word of caution. Libyan Journal of Medicine, 3(2), 84-90.[Link][PubMed][DOI]
  3. Moutzouri, E., Elisaf, M., & Liberopoulos, E. N. (2011). Hypocholesterolemia. Current vascular pharmacology, 9(2), 200-212.[PubMed][DOI]
  4. Iribarren, C., Reed, D. M., Chen, R., Yano, K., & Dwyer, J. H. (1995). Low serum cholesterol and mortality: which is the cause and which is the effect?. Circulation, 92(9), 2396-2403.[PubMed][DOI]
  5. Schatz, I. J., Masaki, K., Yano, K., Chen, R., Rodriguez, B. L., & Curb, J. D. (2001). Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study. The Lancet, 358(9279), 351-355.[PubMed][DOI]
  6. Nago, N., Ishikawa, S., Goto, T., & Kayaba, K. (2011). Low cholesterol is associated with mortality from stroke, heart disease, and cancer: the Jichi Medical School Cohort Study. Journal of epidemiology, 21(1), 67-74.[Link][PubMed][DOI]

Was this article helpful?

Frequently Asked Questions

How can I test my total cholesterol at home?

You can test your total cholesterol at home with SiPhox Health's Core Health Program, which includes total cholesterol testing along with other essential cardiovascular and metabolic biomarkers. For more comprehensive lipid analysis, the Apob Advanced Cholesterol panel provides detailed cholesterol fractionation including ApoA, ApoB, LDL-C, HDL-C, and triglycerides.

What is considered dangerously low total cholesterol?

Total cholesterol below 120 mg/dL is considered unusually low, while levels under 100 mg/dL are dangerously low and require immediate medical evaluation. These levels can indicate serious underlying conditions affecting your liver, thyroid, or digestive system.

Can very low cholesterol cause symptoms?

Yes, very low cholesterol can cause fatigue, mood changes, hormonal imbalances, poor wound healing, and increased infection risk. However, many people remain asymptomatic until complications develop, making regular testing important for those at risk.

Is low cholesterol always bad?

While moderately low cholesterol (140-160 mg/dL) may be fine for some people, very low levels under 120 mg/dL often indicate underlying health problems. Cholesterol is essential for hormone production, cell membrane integrity, and vitamin absorption, so extremely low levels can compromise these vital functions.

How quickly can cholesterol levels change?

Cholesterol levels can change within weeks to months depending on the underlying cause. Treating hyperthyroidism or improving nutrition can raise levels within 4-8 weeks, while recovery from liver disease may take several months. Regular monitoring helps track treatment effectiveness.

This article is licensed under CC BY 4.0. You are free to share and adapt this material with attribution.

Ask Questions About Any Health Topic

Chat with Sai, our AI health assistant, for personalized insights.

Click or drag file to upload blood test results

Backed By Leading Experts in Health Optimization

Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details
Tsolmon Tsogbayar, MD

Tsolmon Tsogbayar, MD

Health Programs Lead, Health Innovation

Dr. Tsogbayar leverages her clinical expertise to develop innovative health solutions and evidence-based coaching. Dr. Tsogbayar previously practiced as a physician with a comprehensive training background, developing specialized expertise in cardiology and emergency medicine after gaining experience in primary care, allergy & immunology, internal medicine, and general surgery.

She earned her medical degree from Imperial College London, where she also completed her MSc in Human Molecular Genetics after obtaining a BSc in Biochemistry from Queen Mary University of London. Her academic research includes significant work in developmental cardiovascular genetics, with her thesis publication contributing to the understanding of genetic modifications on embryonic cardiovascular development.

View Details
Pavel Korecky, MD

Pavel Korecky, MD

Director of Product Operations

Director of Product Operations at SiPhox Health with a background in medicine and a passion for health optimization. Experienced in leading software and clinical development teams, developing MVPs, contributing to patents, and launching health-related products.

Skilled in product operations, technical and non-technical product development, and agile project management, with expertise in diagnostic and medical technology.

View Details
Paul Thompson, MD

Paul Thompson, MD

Advisor

Paul D. Thompson is Chief of Cardiology Emeritus of Hartford Hospital and Professor Emeritus at University of Connecticut Medical School. He has authored over 500 scientific articles on cardiovascular risk factors, the effects of exercise, and beyond. He received National Institutes of Health’s (NIH) Preventive Cardiology Academic Award, and has received NIH funding for multiple studies.

Dr. Thompson’s interests in exercise, general cardiology and sports cardiology originated from his own distance running: he qualified for the 1972 Olympic Marathon Trials as a 3rd year medical student and finished 16th in the 1976 Boston Marathon. Dr. Thompson publishes a blog 500 Rules of Cardiology where he shares lessons and anecdotes that he has learned over his extensive career as a physician, researcher and teacher.

View Details
Ben Bikman, PhD

Ben Bikman, PhD

Advisor

Benjamin Bikman earned his Ph.D. in Bioenergetics and was a postdoctoral fellow with the Duke-National University of Singapore in metabolic disorders. Currently, his professional focus as a scientist and professor (Brigham Young University) is to better understand the role of elevated insulin and nutrient metabolism in regulating obesity, diabetes, and dementia.

In addition to his academic pursuits, Dr. Bikman is the author of Why We Get Sick and How Not To Get Sick.

View Details
Tash Milinkovic, MD

Tash Milinkovic, MD

Health Programs Lead, Heart & Metabolic

Dr. Natasha Milinkovic is part of the clinical product team at SiPhox Health, having graduated from the University of Bristol Medical School. Her medical career includes rotations across medical and surgical specialties, with specialized research in vascular surgery, focusing on recovery and post-operative pain outcomes. Dr. Milinkovic built her expertise in emergency medicine as a clinical fellow at a major trauma center before practicing at a central London teaching hospital throughout the pandemic.

She has contributed to global health initiatives, implementing surgical safety standards and protocols across rural Uganda. Dr. Milinkovic initially joined SiPhox Health to spearhead the health coaching initiative and has been a key contributor in the development and launch of the Heart and Metabolic program. She is passionate about addressing health disparities by building scalable healthcare solutions.

View Details